Vical

Quick facts

Phase 3 pipeline

• allovectin-7 · Oncology
  Allovectin-7 is a DNA-based immunotherapy that delivers the HLA-B7 and β2-microglobulin genes directly into tumor cells to enhance immune recognition and rejection.
• allovectin-7/dacarbazine · Oncology
  Allovectin-7 is a DNA vaccine that targets telomerase, while dacarbazine is a chemotherapy drug that interferes with DNA replication.

Phase 2 pipeline

• VCL-HB01

Phase 1 pipeline

• VCL-HM01
• VCL-IPM1
• VCL-IPT1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vical portfolio CI brief
• Vical pipeline updates RSS